Freakonomics Radio

How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on "dream patients" who aren't representative of a larger population. On the ot…

We tend to think of medicine as a science, but for most of human history it has been scientific-ish at best. In the first episode of a three-part series, we look at the grotesque mistakes produced by…

Standing in line represents a particularly sloppy — and frustrating — way for supply and demand to meet. Why haven't we found a better way to get what we want? Is it possible that we secretly enjoy w…

The bad news: roughly 70 percent of Americans are financially illiterate. The good news: all the important stuff can fit on one index card. Here's how to become your own financial superhero.

It's hard enough to save for a house, tuition, or retirement. So why are we willing to pay big fees for subpar investment returns? Enter the low-cost index fund. The revolution will not be monetized.

The human foot is an evolutionary masterpiece, far more functional than we give it credit for. So why do we encase it in "a coffin" (as one foot scholar calls it) that stymies so much of its ability …

Good intentions are nice, but with so many resources poured into social programs, wouldn't it be even nicer to know what actually works?

Over 40 percent of U.S. births are to unmarried mothers, and the numbers are especially high among the less-educated. Why? One argument is that the decline in good manufacturing jobs led to a decline…

How a pain-in-the-neck girl from rural Virginia came to run the most powerful university in the world.

Charles Koch, the mega-billionaire CEO of Koch Industries and half of the infamous political machine, sees himself as a classical liberal. So why do most Democrats hate him so much? In a rare series …

Charles Koch, the mega-billionaire CEO of Koch Industries and half of the infamous political machine, sees himself as a classical liberal. So why do most Democrats hate him so much? In a rare series …

Steve Levitt, Scott Turow and Bridget Gainer are panelists. For the "Freakonomics" co-author, the attorney and novelist, and the Cook County commissioner it's "game on!" as they tackle competition of…

A breakthrough in genetic technology has given humans more power than ever to change nature. It could help eliminate hunger and disease; it could also lead to the sort of dystopia we used to only rea…

Steve Hilton was the man behind David Cameron's push to remake British politics. Things didn't work out so well there. Now he's trying to launch a new political revolution – from sunny California.

Nearly two percent of America is grassy green. Sure, lawns are beautiful and useful and they smell great. But are the costs — financial, environmental and otherwise — worth the benefits?

A series of academic studies suggest that the wealthy are, to put it bluntly, selfish jerks. It's an easy narrative to swallow — but is it true? A trio of economists set out to test the theory. All i…

As CEO of Microsoft, Steve Ballmer was famous for over-the-top enthusiasm. Now he's brought that same passion to the N.B.A. -- and to a pet project called USAFacts, which performs a sort of fiscal co…

On the Internet, people say all kinds of things they'd never say aloud -- about sex and race, about their true wants and fears. Seth Stephens-Davidowitz has spent years parsing the data. His conclusi…

A kitchen wizard and a nutrition detective talk about the perfect hamburger, getting the most out of garlic, and why you should use vodka in just about everything.

Some people argue that sugar should be regulated, like alcohol and tobacco, on the grounds that it's addictive and toxic. How much sense does that make? We hear from a regulatory advocate, an evidenc…